Does BROLUCIZUMAB-DBLL Cause Retinal vascular occlusion? 112 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Retinal vascular occlusion have been filed in association with BROLUCIZUMAB-DBLL. This represents 4.0% of all adverse event reports for BROLUCIZUMAB-DBLL.
112
Reports of Retinal vascular occlusion with BROLUCIZUMAB-DBLL
4.0%
of all BROLUCIZUMAB-DBLL reports
2
Deaths
10
Hospitalizations
How Dangerous Is Retinal vascular occlusion From BROLUCIZUMAB-DBLL?
Of the 112 reports, 2 (1.8%) resulted in death, 10 (8.9%) required hospitalization.
Is Retinal vascular occlusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROLUCIZUMAB-DBLL. However, 112 reports have been filed with the FAERS database.
What Other Side Effects Does BROLUCIZUMAB-DBLL Cause?
Vitreous floaters (479)
Visual impairment (446)
Vision blurred (416)
Eye inflammation (387)
Visual acuity reduced (365)
Retinal vasculitis (323)
Uveitis (305)
Vitritis (284)
Eye pain (234)
Vitreous opacities (205)
What Other Drugs Cause Retinal vascular occlusion?
VANCOMYCIN (69)
AFLIBERCEPT (36)
ADALIMUMAB (35)
SILDENAFIL (18)
IBRUTINIB (17)
BEVACIZUMAB (16)
RANIBIZUMAB (14)
LENALIDOMIDE (13)
APIXABAN (11)
MELPHALAN (9)
Which BROLUCIZUMAB-DBLL Alternatives Have Lower Retinal vascular occlusion Risk?
BROLUCIZUMAB-DBLL vs BROMAZEPAM
BROLUCIZUMAB-DBLL vs BROMFENAC
BROLUCIZUMAB-DBLL vs BROMHEXINE
BROLUCIZUMAB-DBLL vs BROMOCRIPTINE
BROLUCIZUMAB-DBLL vs BROTIZOLAM